1. Home
  2. OVID
  3. OVID News

Latest Ovid Therapeutics Inc. (OVID) News on April 2, 2025

Ovid Therapeutics Full Year 2024 Earnings: EPS Beats Expectations, Revenues Lag
OVID

Simply Wall St.

21 days ago

Ovid Therapeutics Full Year 2024 Earnings: EPS Beats Expectations, Revenues Lag

OVID

MT Newswires

21 days ago

Wedbush Adjusts Price Target on Ovid Therapeutics to $3 From $4, Keeps Outperform Rating

Ovid Therapeutics (OVID) Reports Q4 Loss, Lags Revenue Estimates
OVID

Zacks

22 days ago

Ovid Therapeutics (OVID) Reports Q4 Loss, Lags Revenue Estimates

Ovid Therapeutics Reports Business Updates and Fourth Quarter and Full Year 2024 Financial Results
OVID

GlobeNewswire

22 days ago

Ovid Therapeutics Reports Business Updates and Fourth Quarter and Full Year 2024 Financial Results

We're A Little Worried About Ovid Therapeutics' (NASDAQ:OVID) Cash Burn Rate
OVID

Simply Wall St.

22 days ago

We're A Little Worried About Ovid Therapeutics' (NASDAQ:OVID) Cash Burn Rate

Ovid Therapeutics Appoints Pioneering Industry Leader Dr. Stelios Papadopoulos to Board of Directors
OVID

GlobeNewswire

a month ago

Ovid Therapeutics Appoints Pioneering Industry Leader Dr. Stelios Papadopoulos to Board of Directors

Ovid Therapeutics to Present at the TD Cowen 45th Annual Health Care Conference
OVID

GlobeNewswire

a month ago

Ovid Therapeutics to Present at the TD Cowen 45th Annual Health Care Conference

Ovid Therapeutics to Present at the Oppenheimer 35th Annual Healthcare Life Sciences Conference
OVID

GlobeNewswire

2 months ago

Ovid Therapeutics to Present at the Oppenheimer 35th Annual Healthcare Life Sciences Conference

Ovid Therapeutics upgraded at Oppenheimer as OV329’s promise ‘quite real’
OVID

TipRanks

2 months ago

Ovid Therapeutics upgraded at Oppenheimer as OV329’s promise ‘quite real’

OVID

Argus Research

2 months ago

Daily – Vickers Top Buyers & Sellers for 01/30/2025

US Penny Stocks To Watch In January 2025
OVID

Simply Wall St.

2 months ago

US Penny Stocks To Watch In January 2025

OVID

MT Newswires

2 months ago

Oppenheimer Upgrades Ovid Therapeutics to Outperform From Perform, $4 Price Target

Ovid Therapeutics Insider Ups Holding During Year
OVID

Simply Wall St.

2 months ago

Ovid Therapeutics Insider Ups Holding During Year

3 US Penny Stocks With Market Caps Over $20M
OVID

Simply Wall St.

4 months ago

3 US Penny Stocks With Market Caps Over $20M

Ovid Therapeutics to Present Multiple Posters Supporting Its Pipeline Programs Targeting Neuronal Hyperexcitability at the American Epilepsy Society 2024 Annual Meeting
OVID

GlobeNewswire

4 months ago

Ovid Therapeutics to Present Multiple Posters Supporting Its Pipeline Programs Targeting Neuronal Hyperexcitability at the American Epilepsy Society 2024 Annual Meeting

Ovid Therapeutics (OVID) Reports Q3 Loss, Tops Revenue Estimates
OVID

Zacks

5 months ago

Ovid Therapeutics (OVID) Reports Q3 Loss, Tops Revenue Estimates

Ovid Therapeutics Reports Business Updates and Third Quarter 2024 Financial Results
OVID

GlobeNewswire

5 months ago

Ovid Therapeutics Reports Business Updates and Third Quarter 2024 Financial Results

US Penny Stocks To Watch This November 2024
OVID

Simply Wall St.

5 months ago

US Penny Stocks To Watch This November 2024

Ovid Therapeutics to Host Investor Event
OVID

GlobeNewswire

5 months ago

Ovid Therapeutics to Host Investor Event

Will Ovid Therapeutics (NASDAQ:OVID) Spend Its Cash Wisely?
OVID

Simply Wall St.

6 months ago

Will Ovid Therapeutics (NASDAQ:OVID) Spend Its Cash Wisely?

Ovid Therapeutics Presents Pre-Clinical Study Results Demonstrating OV329 Does Not Accumulate in Animal Eyes in Contrast with Vigabatrin
OVID

GlobeNewswire

6 months ago

Ovid Therapeutics Presents Pre-Clinical Study Results Demonstrating OV329 Does Not Accumulate in Animal Eyes in Contrast with Vigabatrin

Meg Alexander Takes on Expanded Role as President and COO at Ovid Therapeutics, Strengthening Leadership for Future Growth
OVID

GlobeNewswire

7 months ago

Meg Alexander Takes on Expanded Role as President and COO at Ovid Therapeutics, Strengthening Leadership for Future Growth

Ovid Therapeutics to Present at Upcoming September Investor Conferences
OVID

GlobeNewswire

7 months ago

Ovid Therapeutics to Present at Upcoming September Investor Conferences

Ovid Therapeutics (OVID) Upgraded to Buy: Here's Why
OVID

Zacks

7 months ago

Ovid Therapeutics (OVID) Upgraded to Buy: Here's Why

Ovid Therapeutics (OVID) Q2 Earnings and Revenues Surpass Estimates
OVID

Zacks

8 months ago

Ovid Therapeutics (OVID) Q2 Earnings and Revenues Surpass Estimates

Ovid Therapeutics Reports Business Updates and Second Quarter 2024 Financial Results
OVID

GlobeNewswire

8 months ago

Ovid Therapeutics Reports Business Updates and Second Quarter 2024 Financial Results

Lilly opens R&D hub; Ovid and Lexicon lay off staff
OVID

BioPharma Dive

8 months ago

Lilly opens R&D hub; Ovid and Lexicon lay off staff

Cardiff Oncology (CRDF) Reports Q2 Loss, Tops Revenue Estimates
OVID

Zacks

8 months ago

Cardiff Oncology (CRDF) Reports Q2 Loss, Tops Revenue Estimates

Ovid Therapeutics Appoints Dr. Amanda Banks, Experienced Biotech Leader & Physician as Chief Development Officer
OVID

GlobeNewswire

8 months ago

Ovid Therapeutics Appoints Dr. Amanda Banks, Experienced Biotech Leader & Physician as Chief Development Officer

Ovid Therapeutics to Present at Upcoming August Investor Conferences
OVID

GlobeNewswire

8 months ago

Ovid Therapeutics to Present at Upcoming August Investor Conferences

Ovid Therapeutics Expands Scientific Advisory Board with Appointments of Leading Neurologists, Neuroscientists and Epileptologists
OVID

GlobeNewswire

8 months ago

Ovid Therapeutics Expands Scientific Advisory Board with Appointments of Leading Neurologists, Neuroscientists and Epileptologists

Ovid Therapeutics Inc. (OVID): One of the Best Penny Stocks to Buy Under $1 According to Hedge Funds?
OVID

Insider Monkey

9 months ago

Ovid Therapeutics Inc. (OVID): One of the Best Penny Stocks to Buy Under $1 According to Hedge Funds?

eNeuro Publishes Findings on the Anti-Convulsant Properties of OV329 and Its Potential Effectiveness in Treatment-Resistant Seizures
OVID

GlobeNewswire

9 months ago

eNeuro Publishes Findings on the Anti-Convulsant Properties of OV329 and Its Potential Effectiveness in Treatment-Resistant Seizures

OVID

MT Newswires

9 months ago

Immunic Names Jason Tardio as COO, Werner Gladdines as Chief Development Officer

Ovid Therapeutics and Graviton Bioscience Announce Topline Data from a Phase 1 Clinical Trial Studying OV888/GV101 Capsule, a Potential First-In-Class Therapy for Cerebral Cavernous Malformations
OVID

GlobeNewswire

9 months ago

Ovid Therapeutics and Graviton Bioscience Announce Topline Data from a Phase 1 Clinical Trial Studying OV888/GV101 Capsule, a Potential First-In-Class Therapy for Cerebral Cavernous Malformations

Biotech Stock Roundup: ITCI Up on Study Data, ZNTL, OVID Down on Updates & More News
OVID

Zacks

9 months ago

Biotech Stock Roundup: ITCI Up on Study Data, ZNTL, OVID Down on Updates & More News

OVID Slumps 76% on Epilepsy Drug Failing Two Pivotal Studies
OVID

Zacks

9 months ago

OVID Slumps 76% on Epilepsy Drug Failing Two Pivotal Studies

Apple downgraded, Kroger upgraded: Wall Street's top analyst calls
OVID

The Fly

9 months ago

Apple downgraded, Kroger upgraded: Wall Street's top analyst calls

OVID

MT Newswires

9 months ago

Oppenheimer Downgrades Ovid Therapeutics to Market Perform

OVID

MT Newswires

9 months ago

B. Riley Adjusts Price Target on Ovid Therapeutics to $3 From $9, Maintains Buy Rating

OVID

MT Newswires

9 months ago

BTIG Adjusts Price Target on Ovid Therapeutics to $5 From $11, Maintains Buy Rating

OVID

MT Newswires

9 months ago

HC Wainwright Adjusts Price Target on Ovid Therapeutics to $3 From $9, Maintains Buy Rating

OVID

MT Newswires

9 months ago

Citigroup Adjusts Price Target on Ovid Therapeutics to $1.20 From $3.50, Maintains Neutral Rating

OVID

MT Newswires

10 months ago

Top Midday Decliners

OVID

MT Newswires

10 months ago

Sector Update: Health Care Stocks Decline Premarket Monday

OVID

MT Newswires

10 months ago

Wedbush Lowers PT on Ovid Therapeutics to $4 From $8 After Soticlestat Missed Endpoints in Phase 3 Studies; Maintains Outperform Rating

OVID

MT Newswires

10 months ago

Ovid Seeks Distance From Epilepsy Drug After Takeda Reports Phase 3 Endpoints Missed -- Pre-Bell Shares Fall

Takeda drug for rare types of epilepsy misses goal in late-stage trial
OVID

BioPharma Dive

10 months ago

Takeda drug for rare types of epilepsy misses goal in late-stage trial

OVID

MT Newswires

10 months ago

Top Premarket Decliners

Ovid Therapeutics Reports on Takeda’s Announcement of Phase 3 Topline Study Results for Soticlestat
OVID

GlobeNewswire

10 months ago

Ovid Therapeutics Reports on Takeda’s Announcement of Phase 3 Topline Study Results for Soticlestat

[Latest] Global Virtual Reality In Gaming Market Size/Share Worth USD 103,244.7 Million by 2033 at a 16.5% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth, Growth Rate, Value)
OVID

GlobeNewswire

10 months ago

[Latest] Global Virtual Reality In Gaming Market Size/Share Worth USD 103,244.7 Million by 2033 at a 16.5% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth, Growth Rate, Value)

OVID

Business Wire

10 months ago

Net Asset Value(s)

CCF Group Successful €225m AT1 Issuance
OVID

Business Wire

10 months ago

CCF Group Successful €225m AT1 Issuance

Should You Hold 908 Devices (MASS)?
OVID

Insider Monkey

10 months ago

Should You Hold 908 Devices (MASS)?

Bangladesh Ecommerce Market Report 2024, Featuring Daraz Bangladesh, Chaldal, Evaly, Pickaboo and Ajkerdeal - Forecasts to 2028
OVID

GlobeNewswire

10 months ago

Bangladesh Ecommerce Market Report 2024, Featuring Daraz Bangladesh, Chaldal, Evaly, Pickaboo and Ajkerdeal - Forecasts to 2028

3 Major Product Releases at 3Shape Discover Event
OVID

PR Newswire

10 months ago

3 Major Product Releases at 3Shape Discover Event

Calculating The Fair Value Of Mincon Group plc (LON:MCON)
OVID

Simply Wall St.

10 months ago

Calculating The Fair Value Of Mincon Group plc (LON:MCON)

Flash News: OKX Launches 'Trade and Earn' Campaign Featuring 2,500,000 Ultiverse Tokens
OVID

GlobeNewswire

10 months ago

Flash News: OKX Launches 'Trade and Earn' Campaign Featuring 2,500,000 Ultiverse Tokens

Ovid Therapeutics (OVID) Reports Q1 Loss, Tops Revenue Estimates
OVID

Zacks

a year ago

Ovid Therapeutics (OVID) Reports Q1 Loss, Tops Revenue Estimates

Ovid Therapeutics Reports Business Updates and First Quarter 2024 Financial Results
OVID

GlobeNewswire

a year ago

Ovid Therapeutics Reports Business Updates and First Quarter 2024 Financial Results

Ovid Therapeutics to Present at the H.C. Wainwright 2nd Annual BioConnect Investor Conference
OVID

GlobeNewswire

a year ago

Ovid Therapeutics to Present at the H.C. Wainwright 2nd Annual BioConnect Investor Conference

Beam Therapeutics Inc. (BEAM) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
OVID

Zacks

a year ago

Beam Therapeutics Inc. (BEAM) Expected to Beat Earnings Estimates: Can the Stock Move Higher?

OVID

MT Newswires

a year ago

B. Riley Securities Initiates Ovid Therapeutics With Buy Rating, $9 Price Target

OVID

MT Newswires

a year ago

HC Wainwright Starts Ovid Therapeutics With Buy Rating, $9 Price Target

Ovid Therapeutics (OVID) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
OVID

Zacks

a year ago

Ovid Therapeutics (OVID) Expected to Beat Earnings Estimates: Can the Stock Move Higher?

We Think Ovid Therapeutics (NASDAQ:OVID) Can Afford To Drive Business Growth
OVID

Simply Wall St.

a year ago

We Think Ovid Therapeutics (NASDAQ:OVID) Can Afford To Drive Business Growth

Ovid Therapeutics to Present at the 23rd Annual Needham Virtual Healthcare Conference
OVID

GlobeNewswire

a year ago

Ovid Therapeutics to Present at the 23rd Annual Needham Virtual Healthcare Conference

Ovid Therapeutics Reaches US$197m Market Cap Benefiting Insider Stock Buying
OVID

Simply Wall St.

a year ago

Ovid Therapeutics Reaches US$197m Market Cap Benefiting Insider Stock Buying

Ovid Therapeutics Reports Business Updates, Fourth Quarter and Full Year 2023 Financial Results
OVID

GlobeNewswire

a year ago

Ovid Therapeutics Reports Business Updates, Fourth Quarter and Full Year 2023 Financial Results

Ovid Therapeutics to Present at the TD Cowen 44th Annual Health Care Conference
OVID

GlobeNewswire

a year ago

Ovid Therapeutics to Present at the TD Cowen 44th Annual Health Care Conference

Ovid Therapeutics to Present at the Oppenheimer 34th Annual Healthcare Life Sciences Conference
OVID

GlobeNewswire

a year ago

Ovid Therapeutics to Present at the Oppenheimer 34th Annual Healthcare Life Sciences Conference

OVID

Zacks Small Cap Research

a year ago

SCLX Sees Accelerating Revenue Growth

IDEAYA Biosciences Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
OVID

PR Newswire

a year ago

IDEAYA Biosciences Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

PCB Bancorp (PCB) Q4 Earnings and Revenues Lag Estimates
OVID

Zacks

a year ago

PCB Bancorp (PCB) Q4 Earnings and Revenues Lag Estimates

i-80 Gold Reports High-Grade Drill Results from the FAD Deposit at Ruby Hill
OVID

CNW Group

a year ago

i-80 Gold Reports High-Grade Drill Results from the FAD Deposit at Ruby Hill

Business First Bancshares, Inc., Announces Financial Results for Fiscal Year 2023 and Q4 2023
OVID

GlobeNewswire

a year ago

Business First Bancshares, Inc., Announces Financial Results for Fiscal Year 2023 and Q4 2023

4 Stocks to Watch From the Flourishing Water Supply Industry
OVID

Zacks

a year ago

4 Stocks to Watch From the Flourishing Water Supply Industry

Stitch Fix (SFIX) Fortifies With AI Amid Market Challenges
OVID

Zacks

a year ago

Stitch Fix (SFIX) Fortifies With AI Amid Market Challenges

Owning 31% shares,hedge funds owners seem interested in Ovid Therapeutics Inc. (NASDAQ:OVID),
OVID

Simply Wall St.

a year ago

Owning 31% shares,hedge funds owners seem interested in Ovid Therapeutics Inc. (NASDAQ:OVID),

OVID

GuruFocus.com

a year ago

NVE Corp (NVEC) Reports Decrease in Q3 Revenue and Net Income, Maintains Dividend

OVID

Associated Press Finance

a year ago

NVE: Fiscal Q3 Earnings Snapshot

NVE Corporation Reports Third Quarter Results and Announces Quarterly Dividend
OVID

GlobeNewswire

a year ago

NVE Corporation Reports Third Quarter Results and Announces Quarterly Dividend

Annexon (ANNX) Stock Rallies 156% in 3 Months: Here's How
OVID

Zacks

a year ago

Annexon (ANNX) Stock Rallies 156% in 3 Months: Here's How

Ardmore Shipping (ASC) Suffers a Larger Drop Than the General Market: Key Insights
OVID

Zacks

a year ago

Ardmore Shipping (ASC) Suffers a Larger Drop Than the General Market: Key Insights

Liberty All-Star® Growth Fund, Inc. December 2023 Monthly Update
OVID

PR Newswire

a year ago

Liberty All-Star® Growth Fund, Inc. December 2023 Monthly Update

Scilex Holding Company Chief Executive Officer and President Issues Letter to Stockholders Highlighting 2023 Accomplishments and Outlook for 2024
OVID

GlobeNewswire

a year ago

Scilex Holding Company Chief Executive Officer and President Issues Letter to Stockholders Highlighting 2023 Accomplishments and Outlook for 2024

Financial Institutions, Inc. Schedules Fourth Quarter and Full Year 2023 Earnings Release and Conference Call
OVID

GlobeNewswire

a year ago

Financial Institutions, Inc. Schedules Fourth Quarter and Full Year 2023 Earnings Release and Conference Call

NewtekOne, Inc. Announces Record Loan Closings for the Fourth Quarter and Full Year 2023
OVID

GlobeNewswire

a year ago

NewtekOne, Inc. Announces Record Loan Closings for the Fourth Quarter and Full Year 2023

DoubleLine Opportunistic Credit Fund Declares January 2024 Distribution
OVID

PR Newswire

a year ago

DoubleLine Opportunistic Credit Fund Declares January 2024 Distribution

Scilex Holding Company Provides Certain Preliminary Unaudited Financial Results For Gross And Net Sales For The Fiscal Year Ended December 31, 2023, Based On Currently Available Information
OVID

GlobeNewswire

a year ago

Scilex Holding Company Provides Certain Preliminary Unaudited Financial Results For Gross And Net Sales For The Fiscal Year Ended December 31, 2023, Based On Currently Available Information

OVID

Business Wire

a year ago

ASA Gold and Precious Metals Fund Adopts Limited-Duration Shareholder Rights Plan

12 Most Profitable Pot Stocks Now
OVID

Insider Monkey

a year ago

12 Most Profitable Pot Stocks Now

Investors in MidWestOne Financial Group (NASDAQ:MOFG) have unfortunately lost 12% over the last year
OVID

Simply Wall St.

a year ago

Investors in MidWestOne Financial Group (NASDAQ:MOFG) have unfortunately lost 12% over the last year

Dividend Stocks: Ares Commercial REIT Sizzles With 12.1% Yield
OVID

Investor's Business Daily

a year ago

Dividend Stocks: Ares Commercial REIT Sizzles With 12.1% Yield

Is Barrett Business Services (BBSI) Stock Undervalued Right Now?
OVID

Zacks

a year ago

Is Barrett Business Services (BBSI) Stock Undervalued Right Now?

3 Penny Stocks That Are About to Get Absolutely Crushed
OVID

InvestorPlace

a year ago

3 Penny Stocks That Are About to Get Absolutely Crushed

SoundThinking (NASDAQ:SSTI) shareholders have endured a 28% loss from investing in the stock three years ago
OVID

Simply Wall St.

a year ago

SoundThinking (NASDAQ:SSTI) shareholders have endured a 28% loss from investing in the stock three years ago

SoundThinking Expands into Latin America with Launch of ShotSpotter in Montevideo, Uruguay
OVID

GlobeNewswire

a year ago

SoundThinking Expands into Latin America with Launch of ShotSpotter in Montevideo, Uruguay

Director Biotech Wg's Strategic Investment in Y-mAbs Therapeutics Inc
OVID

GuruFocus.com

a year ago

Director Biotech Wg's Strategic Investment in Y-mAbs Therapeutics Inc

Sun Country Airlines Holdings, Inc. Announces Launch of Secondary Public Offering of Common Stock and Concurrent Share Repurchase
OVID

GlobeNewswire

a year ago

Sun Country Airlines Holdings, Inc. Announces Launch of Secondary Public Offering of Common Stock and Concurrent Share Repurchase

Share on Social Networks: